Results 101 to 110 of about 6,944 (246)

Sex Differences in [68Ga]Ga‐NODAGA‐Exendin‐4 Uptake in the Pituitary of Individuals With Type 2 Diabetes

Diabetes, Obesity and Metabolism, EarlyView.
Sevilay Tokgöz, Marti Boss, Rick I. Meijer, Theodorus J. P. Jansen, Laura N. Deden, Cees J. Tack, Bastiaan E. de Galan, Martin Gotthardt   +7 more
wiley   +1 more source

Clinical significance of renal histological diagnosis in patients with type 2 diabetes and proteinuria atypical for diabetic nephropathy

Journal of Diabetes Investigation, EarlyView.
ABSTRACT Background/Aim Most patients with proteinuria are considered to have typical diabetic nephropathy (DN). However, when proteinuria occurs without diabetic retinopathy, with hematuria, or persists despite strict glycemic and blood pressure control, it is considered atypical for DN and warrants further evaluation for non‐DN via kidney biopsy ...
Shogo Kuwagata, Masami Chin‐Kanasaki, Aki Yamada, Tomonori Sakae, Nahomi Ishimoto, Yoshimi Imamura‐Uehara, Kosuke Yamahara, Mako Yasuda‐Yamahara, Sho Sugahara, Yuki Tanaka‐Sasaki, Natsumi Kuwata, Kimihiro Nishimura, Koichiro Murata, Itsuko Miyazawa, Shogo Ida, Natsuko Ohashi, Shinji Kume   +16 more
wiley   +1 more source

SGLT2 inhibitors and GLP-1 receptor agonists: impact on mortality in diabetic patients with cardiovascular disease

Cardiovascular Diabetology
Background Sodium-glucose cotransporter 2 inhibitors (SGLT2-I) and glucagon-like peptide-1 receptor agonists (GLP-1RA) have been shown to reduce cardiovascular risk and mortality in patients with type 2 diabetes mellitus (T2D), yet remain underutilized ...
Ziad Arow, Tzipi Hornik-Lurie, Ranin Hilu, Ela Giladi, Yoav Arnson, Hana Vaknin-Assa, Abid Assali, David Pereg, For the CARDIAB research group   +8 more
doaj   +1 more source

The Role of GLP-1 Receptor Agonists in Eating Disorders: Appetite Regulation and Neurobiological Mechanisms

Neurologijos seminarai
Valgymo sutrikimai, tokie kaip nervinė anoreksija, nervinė bulimija ir persivalgymo sutrikimas, dažnai siejami su neurobiologinėmis disfunkcijomis, įskaitant dopamino ir atlygio sistemų pokyčius.
Julija Blažytė, Robertas Strumila
doaj   +1 more source

Interpreting Pregnancy Risk After GLP‐1 Receptor Agonists Discontinuation

Diabetes, Obesity and Metabolism, EarlyView.
Roberta Scairati, Christine Newman, Fidelma P. Dunne, Annamaria Colao   +3 more
wiley   +1 more source

Impact of renal function on antidiabetic drug selection in Japan: A real‐world analysis using the J‐DREAMS database

Journal of Diabetes Investigation, EarlyView.
Using a large Japanese real‐world database, we examined antidiabetic drug selection in first and second therapy stratified by renal function and study period. The earlier initiation of SGLT2 inhibitors and GLP‐1 receptor agonists increased over time, particularly in second therapy, with prescribing patterns increasingly aligned across renal function ...
Masashi Kubota, Mitsuru Ohsugi, Kohjiro Ueki   +2 more
wiley   +1 more source

Additive effects of GLY-200 (oral pharmacologic duodenal exclusion therapy) and GLP-1R agonist in obesity management

Molecular Metabolism
Type 2 diabetes and obesity impact billions of people and the global prevalence is only growing. Current treatment options, which include pharmacotherapy, e.g., GLP-1 receptor agonists (GLP-1RA) and bariatric surgical approaches have limitations. GLY-200
Taylor L. Carlson, Mark Fineman, Stace Kernodle, Chelsea R. Hutch, Christine Bryant, Kevin Colbert, Randy J. Seeley, Ashish Nimgaonkar   +7 more
doaj   +1 more source

Association of Tirzepatide With Kidney Parameters in Participants With Obesity and Prediabetes From SURMOUNT‐1 Over 176 Weeks

Diabetes, Obesity and Metabolism, EarlyView.
Hiddo J. L. Heerspink, Daniel H. van Raalte, Katherine Tuttle, David Z. I. Cherney, Petter Bjornstad, Dachuang Cao, Georgios K. Dimitriadis, Bruno Linetzky, Irina Jouravskaya, Mathijs C. Bunck, Ryan Griffin, Claire Gerber   +11 more
wiley   +1 more source

Nutrition Strategies for Next‐Generation Incretin Therapies: A Systematic Scoping Review of the Current Evidence

Obesity Reviews, EarlyView.
ABSTRACT Next‐generation incretin therapies, including semaglutide and tirzepatide, have transformed obesity and Type 2 diabetes management. However, evidence‐based nutritional strategies to support safe and effective use of these agents remain limited.
Marie Spreckley, Cara F. Ruggiero, Adrian Brown   +2 more
wiley   +1 more source

Risk of Phimosis Associated with SGLT2i versus GLP-1RA: A Danish Cohort Study

Diabetes Care
<p dir="ltr"><b>Objective</b></p><p dir="ltr">Sodium-glucose cotransporter 2 inhibitors (SGLT2is) induce glucosuria, potentially leading to infection and inflammation in the preputial microenvironment, subsequently increasing the risk of phimosis.
Christine Ljungberg, Mette Nørgaard, Christina Vandenbroucke-Grauls, Jakob Kristian Jakobsen, Morten Haaning Charles, Anton Pottegård, Michael Dalager-Pedersen, Henrik Toft Sørensen, Reimar Wernich Thomsen   +8 more
openaire   +2 more sources